PF4 and autoimmune thrombocytopenic purpura: Besides VITT, cases of immune thrombocytopenia (ITP) after AstraZeneca (ChAdOx1 nCoV-19) vaccination have been reported, yet antibodies associated with this condition (including anti-PF4 antibodies) have not been identified to date (29, 30).